

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.77375276 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.77375276 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.35150711 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.30341452 |
| 5 | ribosomal small subunit assembly (GO:0000028) | 5.26378426 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.94075264 |
| 7 | response to peptidoglycan (GO:0032494) | 4.65452564 |
| 8 | negative regulation of interleukin-12 production (GO:0032695) | 4.54978338 |
| 9 | viral transcription (GO:0019083) | 4.39349887 |
| 10 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.35369045 |
| 11 | translational termination (GO:0006415) | 4.20308359 |
| 12 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.18323060 |
| 13 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.06180836 |
| 14 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.93360371 |
| 15 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.84182490 |
| 16 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.79367055 |
| 17 | positive regulation of B cell differentiation (GO:0045579) | 3.76360457 |
| 18 | DNA deamination (GO:0045006) | 3.74437947 |
| 19 | regulation of gamma-delta T cell activation (GO:0046643) | 3.70421416 |
| 20 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.67832853 |
| 21 | macrophage activation involved in immune response (GO:0002281) | 3.65170380 |
| 22 | T-helper 1 type immune response (GO:0042088) | 3.64999198 |
| 23 | translational elongation (GO:0006414) | 3.62064488 |
| 24 | regulation of podosome assembly (GO:0071801) | 3.57611439 |
| 25 | protein targeting to ER (GO:0045047) | 3.57202696 |
| 26 | cotranslational protein targeting to membrane (GO:0006613) | 3.56674750 |
| 27 | regulation of vitamin metabolic process (GO:0030656) | 3.54150927 |
| 28 | germinal center formation (GO:0002467) | 3.50142120 |
| 29 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.49739641 |
| 30 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.49688406 |
| 31 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.47443348 |
| 32 | ribosomal small subunit biogenesis (GO:0042274) | 3.46657748 |
| 33 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.43358712 |
| 34 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.42405464 |
| 35 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.41928023 |
| 36 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.41738195 |
| 37 | * positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.41492337 |
| 38 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.39057900 |
| 39 | protein localization to endoplasmic reticulum (GO:0070972) | 3.35798653 |
| 40 | immunoglobulin mediated immune response (GO:0016064) | 3.32472949 |
| 41 | viral life cycle (GO:0019058) | 3.27910078 |
| 42 | response to muramyl dipeptide (GO:0032495) | 3.25588365 |
| 43 | mast cell activation (GO:0045576) | 3.25040784 |
| 44 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.24839070 |
| 45 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.24625245 |
| 46 | regulation of B cell differentiation (GO:0045577) | 3.22873203 |
| 47 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.20344888 |
| 48 | regulation of interferon-alpha production (GO:0032647) | 3.20023557 |
| 49 | regulation of chemokine biosynthetic process (GO:0045073) | 3.19503002 |
| 50 | glycosphingolipid catabolic process (GO:0046479) | 3.18555967 |
| 51 | response to interferon-beta (GO:0035456) | 3.18363763 |
| 52 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.18213503 |
| 53 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.16343381 |
| 54 | maturation of SSU-rRNA (GO:0030490) | 3.16073969 |
| 55 | leukocyte aggregation (GO:0070486) | 3.13119162 |
| 56 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.12110041 |
| 57 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.10772784 |
| 58 | regulation of mononuclear cell migration (GO:0071675) | 3.10588016 |
| 59 | cellular protein complex disassembly (GO:0043624) | 3.10585861 |
| 60 | mature B cell differentiation involved in immune response (GO:0002313) | 3.09139523 |
| 61 | response to protozoan (GO:0001562) | 3.07173002 |
| 62 | defense response to protozoan (GO:0042832) | 3.05078306 |
| 63 | mature B cell differentiation (GO:0002335) | 3.03434545 |
| 64 | response to type I interferon (GO:0034340) | 3.01927636 |
| 65 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.01756979 |
| 66 | T cell homeostasis (GO:0043029) | 3.01667974 |
| 67 | regulation of antigen processing and presentation (GO:0002577) | 3.01283778 |
| 68 | myeloid dendritic cell activation (GO:0001773) | 3.00352088 |
| 69 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.00224861 |
| 70 | type I interferon signaling pathway (GO:0060337) | 3.00035826 |
| 71 | cellular response to type I interferon (GO:0071357) | 3.00035826 |
| 72 | translational initiation (GO:0006413) | 2.99122286 |
| 73 | dendritic cell differentiation (GO:0097028) | 2.97307755 |
| 74 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.96736196 |
| 75 | regulation of mast cell degranulation (GO:0043304) | 2.96286079 |
| 76 | amino sugar catabolic process (GO:0046348) | 2.95044092 |
| 77 | interferon-gamma production (GO:0032609) | 2.94528358 |
| 78 | negative regulation of cell killing (GO:0031342) | 2.93228091 |
| 79 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.93228091 |
| 80 | definitive hemopoiesis (GO:0060216) | 2.92896335 |
| 81 | negative T cell selection (GO:0043383) | 2.92794721 |
| 82 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.91271586 |
| 83 | oligosaccharide catabolic process (GO:0009313) | 2.91209997 |
| 84 | regulation of chronic inflammatory response (GO:0002676) | 2.90741019 |
| 85 | B cell mediated immunity (GO:0019724) | 2.89088254 |
| 86 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.88068185 |
| 87 | granulocyte activation (GO:0036230) | 2.87885320 |
| 88 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.87736191 |
| 89 | negative thymic T cell selection (GO:0045060) | 2.87530972 |
| 90 | positive regulation of granulocyte differentiation (GO:0030854) | 2.86681527 |
| 91 | response to interleukin-15 (GO:0070672) | 2.84442655 |
| 92 | response to thyroid hormone (GO:0097066) | 2.83836274 |
| 93 | glycolipid catabolic process (GO:0019377) | 2.82870886 |
| 94 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.82148295 |
| 95 | telomere maintenance via recombination (GO:0000722) | 2.81374183 |
| 96 | protein localization to endosome (GO:0036010) | 2.81156468 |
| 97 | cellular response to interferon-beta (GO:0035458) | 2.80669407 |
| 98 | monocyte chemotaxis (GO:0002548) | 2.79034651 |
| 99 | DNA strand elongation (GO:0022616) | 2.78303965 |
| 100 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.77521463 |
| 101 | positive thymic T cell selection (GO:0045059) | 2.74788728 |
| 102 | erythrocyte maturation (GO:0043249) | 2.74777693 |
| 103 | cellular response to interferon-gamma (GO:0071346) | 2.74729729 |
| 104 | protein complex disassembly (GO:0043241) | 2.74696036 |
| 105 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.74581225 |
| 106 | Peyers patch development (GO:0048541) | 2.74581225 |
| 107 | cellular response to lipopolysaccharide (GO:0071222) | 2.74265465 |
| 108 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.73470813 |
| 109 | positive regulation of heat generation (GO:0031652) | 2.73120707 |
| 110 | pinocytosis (GO:0006907) | 2.73113613 |
| 111 | NIK/NF-kappaB signaling (GO:0038061) | 2.70821014 |
| 112 | T cell migration (GO:0072678) | 2.70803544 |
| 113 | positive regulation of type 2 immune response (GO:0002830) | 2.70299390 |
| 114 | neutrophil activation involved in immune response (GO:0002283) | 2.69889176 |
| 115 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.69737689 |
| 116 | lymph node development (GO:0048535) | 2.69472457 |
| 117 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.69434565 |
| 118 | modulation by symbiont of host cellular process (GO:0044068) | 2.69155640 |
| 119 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.68691336 |
| 120 | regulation of leukocyte degranulation (GO:0043300) | 2.68654523 |
| 121 | positive regulation of macrophage differentiation (GO:0045651) | 2.68543996 |
| 122 | positive regulation of isotype switching (GO:0045830) | 2.67064623 |
| 123 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.66612645 |
| 124 | regulation of erythrocyte differentiation (GO:0045646) | 2.66611763 |
| 125 | activation of MAPKKK activity (GO:0000185) | 2.66510364 |
| 126 | myeloid cell activation involved in immune response (GO:0002275) | 2.66507641 |
| 127 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.64735880 |
| 128 | cellular response to molecule of bacterial origin (GO:0071219) | 2.64182008 |
| 129 | regulation of superoxide anion generation (GO:0032928) | 2.63938173 |
| 130 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.63351634 |
| 131 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.62982629 |
| 132 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.62773972 |
| 133 | positive regulation of antigen processing and presentation (GO:0002579) | 2.62772639 |
| 134 | cellular response to arsenic-containing substance (GO:0071243) | 2.62417603 |
| 135 | positive regulation of leukocyte degranulation (GO:0043302) | 2.62158625 |
| 136 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.62007330 |
| 137 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.60564669 |
| 138 | regulation of interleukin-12 production (GO:0032655) | 2.60259407 |
| 139 | B cell receptor signaling pathway (GO:0050853) | 2.60043467 |
| 140 | barbed-end actin filament capping (GO:0051016) | 2.59665541 |
| 141 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.59301528 |
| 142 | * regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.58681719 |
| 143 | myeloid dendritic cell differentiation (GO:0043011) | 2.58302191 |
| 144 | response to interferon-alpha (GO:0035455) | 2.57740738 |
| 145 | lymphocyte homeostasis (GO:0002260) | 2.57310110 |
| 146 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.56974460 |
| 147 | regulation of cholesterol storage (GO:0010885) | 2.56844042 |
| 148 | negative regulation of phagocytosis (GO:0050765) | 2.56709259 |
| 149 | DNA replication initiation (GO:0006270) | 2.56464463 |
| 150 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.56394052 |
| 151 | detection of other organism (GO:0098543) | 2.56286836 |
| 152 | response to interferon-gamma (GO:0034341) | 2.54872312 |
| 153 | megakaryocyte development (GO:0035855) | 2.54628550 |
| 154 | macromolecular complex disassembly (GO:0032984) | 2.54462141 |
| 155 | * regulation of T cell receptor signaling pathway (GO:0050856) | 2.54425967 |
| 156 | actin nucleation (GO:0045010) | 2.53906537 |
| 157 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.53679241 |
| 158 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.53679241 |
| 159 | modulation by symbiont of host immune response (GO:0052553) | 2.53679241 |
| 160 | positive regulation by symbiont of host defense response (GO:0052509) | 2.53679241 |
| 161 | modulation by symbiont of host defense response (GO:0052031) | 2.53679241 |
| 162 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.53679241 |
| 163 | positive regulation of interferon-alpha production (GO:0032727) | 2.53236353 |
| 164 | detection of bacterium (GO:0016045) | 2.53104436 |
| 165 | mitotic recombination (GO:0006312) | 2.49707183 |
| 166 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.49419494 |
| 167 | ribosomal large subunit biogenesis (GO:0042273) | 2.48286321 |
| 168 | leukocyte homeostasis (GO:0001776) | 2.48121313 |
| 169 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.43385245 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.71886449 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.79190383 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.22255132 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.06558168 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.03176428 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.91631813 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.85077163 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.83851845 |
| 9 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.83338438 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.80838748 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.67058631 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.65814779 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.51994885 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.40534365 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.37800861 |
| 16 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.36911423 |
| 17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.35146104 |
| 18 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.34342377 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.30681948 |
| 20 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.30273932 |
| 21 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.29088036 |
| 22 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.28532998 |
| 23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.24564399 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.20036867 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.13387457 |
| 26 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.10554975 |
| 27 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.03413640 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 2.02322480 |
| 29 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.02183380 |
| 30 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.99203493 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 1.98731271 |
| 32 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.96156330 |
| 33 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.94446541 |
| 34 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.93247711 |
| 35 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.91428526 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.87980576 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.84321786 |
| 38 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83563569 |
| 39 | MYB_26560356_Chip-Seq_TH1_Human | 1.80763587 |
| 40 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.80371293 |
| 41 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.80220468 |
| 42 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.79998258 |
| 43 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.75475704 |
| 44 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.75398548 |
| 45 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.72574631 |
| 46 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.71702534 |
| 47 | UTX_26944678_Chip-Seq_JUKART_Human | 1.69794991 |
| 48 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.68999711 |
| 49 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.68067695 |
| 50 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.67900781 |
| 51 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.67677442 |
| 52 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.67464295 |
| 53 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.63038183 |
| 54 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.62034697 |
| 55 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.61265663 |
| 56 | GATA1_22025678_ChIP-Seq_K562_Human | 1.61015711 |
| 57 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.59542419 |
| 58 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.59295385 |
| 59 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56256416 |
| 60 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.56013928 |
| 61 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.55013845 |
| 62 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.54387859 |
| 63 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.49957744 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.48251291 |
| 65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.45944813 |
| 66 | MAF_26560356_Chip-Seq_TH2_Human | 1.45936872 |
| 67 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.45703842 |
| 68 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.45558176 |
| 69 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.44526497 |
| 70 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.44474496 |
| 71 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.43908141 |
| 72 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.43057415 |
| 73 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.42628870 |
| 74 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.42070789 |
| 75 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.41081670 |
| 76 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40845356 |
| 77 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.40393295 |
| 78 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.38386795 |
| 79 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.38086913 |
| 80 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.36531392 |
| 81 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.36360012 |
| 82 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35505360 |
| 83 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.34815606 |
| 84 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.33303662 |
| 85 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.31856619 |
| 86 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.30295488 |
| 87 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.25131087 |
| 88 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.24879778 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.23765206 |
| 90 | SPI1_23127762_ChIP-Seq_K562_Human | 1.23101436 |
| 91 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.22785262 |
| 92 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21738447 |
| 93 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.21412152 |
| 94 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.20931506 |
| 95 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.20467281 |
| 96 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.19976798 |
| 97 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.19739077 |
| 98 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.17811528 |
| 99 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16709880 |
| 100 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16601846 |
| 101 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16392035 |
| 102 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.16387253 |
| 103 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.16062148 |
| 104 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.15713843 |
| 105 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.14823346 |
| 106 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.14135898 |
| 107 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.13862944 |
| 108 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11911423 |
| 109 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.11808143 |
| 110 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.11597505 |
| 111 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11367237 |
| 112 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11272531 |
| 113 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.10995911 |
| 114 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.10879136 |
| 115 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.10829399 |
| 116 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07157466 |
| 117 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07041964 |
| 118 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06176873 |
| 119 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.05710484 |
| 120 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04891494 |
| 121 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04704916 |
| 122 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.04607896 |
| 123 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.02727582 |
| 124 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02624904 |
| 125 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.01865631 |
| 126 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.01285104 |
| 127 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.01050246 |
| 128 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.00559750 |
| 129 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99634984 |
| 130 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95957845 |
| 131 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95107349 |
| 132 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94718655 |
| 133 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.94415848 |
| 134 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.94315752 |
| 135 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.93426397 |
| 136 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.92721954 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.85677916 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.18780998 |
| 3 | MP0002396_abnormal_hematopoietic_system | 3.14767677 |
| 4 | MP0000685_abnormal_immune_system | 3.13534185 |
| 5 | MP0005671_abnormal_response_to | 3.09478558 |
| 6 | MP0009785_altered_susceptibility_to | 2.92209007 |
| 7 | MP0003436_decreased_susceptibility_to | 2.82882993 |
| 8 | MP0009840_abnormal_foam_cell | 2.82872070 |
| 9 | MP0001800_abnormal_humoral_immune | 2.61659408 |
| 10 | MP0005025_abnormal_response_to | 2.60842761 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.60716752 |
| 12 | MP0002398_abnormal_bone_marrow | 2.49753146 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.48948782 |
| 14 | MP0002723_abnormal_immune_serum | 2.41650164 |
| 15 | MP0009333_abnormal_splenocyte_physiolog | 2.41420077 |
| 16 | * MP0002420_abnormal_adaptive_immunity | 2.40751565 |
| 17 | * MP0001819_abnormal_immune_cell | 2.39128128 |
| 18 | MP0002148_abnormal_hypersensitivity_rea | 2.38260955 |
| 19 | MP0005387_immune_system_phenotype | 2.37588950 |
| 20 | MP0001790_abnormal_immune_system | 2.37588950 |
| 21 | MP0005451_abnormal_body_composition | 2.31746396 |
| 22 | MP0000490_abnormal_crypts_of | 2.29367269 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.29320524 |
| 24 | MP0002419_abnormal_innate_immunity | 2.24673017 |
| 25 | MP0003303_peritoneal_inflammation | 2.20240165 |
| 26 | MP0003806_abnormal_nucleotide_metabolis | 2.18524290 |
| 27 | MP0002166_altered_tumor_susceptibility | 2.15313896 |
| 28 | MP0003075_altered_response_to | 2.13481818 |
| 29 | * MP0000689_abnormal_spleen_morphology | 2.12560321 |
| 30 | MP0003724_increased_susceptibility_to | 2.12084955 |
| 31 | MP0000716_abnormal_immune_system | 2.11039989 |
| 32 | MP0004808_abnormal_hematopoietic_stem | 2.06811920 |
| 33 | * MP0001545_abnormal_hematopoietic_system | 2.06737216 |
| 34 | * MP0005397_hematopoietic_system_phenotyp | 2.06737216 |
| 35 | * MP0002722_abnormal_immune_system | 2.05385187 |
| 36 | MP0002405_respiratory_system_inflammati | 2.05367095 |
| 37 | MP0010155_abnormal_intestine_physiology | 2.05122629 |
| 38 | MP0002139_abnormal_hepatobiliary_system | 2.00360189 |
| 39 | MP0001873_stomach_inflammation | 1.97859649 |
| 40 | MP0003693_abnormal_embryo_hatching | 1.91624136 |
| 41 | * MP0002429_abnormal_blood_cell | 1.91129899 |
| 42 | MP0006082_CNS_inflammation | 1.87024559 |
| 43 | MP0001853_heart_inflammation | 1.85620139 |
| 44 | MP0005174_abnormal_tail_pigmentation | 1.83536922 |
| 45 | MP0003300_gastrointestinal_ulcer | 1.83513469 |
| 46 | MP0003453_abnormal_keratinocyte_physiol | 1.83260617 |
| 47 | MP0002006_tumorigenesis | 1.82836679 |
| 48 | MP0003866_abnormal_defecation | 1.78502348 |
| 49 | * MP0003656_abnormal_erythrocyte_physiolo | 1.78346101 |
| 50 | MP0000703_abnormal_thymus_morphology | 1.77661879 |
| 51 | MP0000604_amyloidosis | 1.76225276 |
| 52 | MP0004147_increased_porphyrin_level | 1.72317001 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.69703106 |
| 54 | MP0001845_abnormal_inflammatory_respons | 1.63977935 |
| 55 | MP0004947_skin_inflammation | 1.56344058 |
| 56 | MP0000858_altered_metastatic_potential | 1.53993465 |
| 57 | MP0005075_abnormal_melanosome_morpholog | 1.53220109 |
| 58 | MP0009278_abnormal_bone_marrow | 1.49234121 |
| 59 | MP0010094_abnormal_chromosome_stability | 1.46220877 |
| 60 | MP0008057_abnormal_DNA_replication | 1.40456430 |
| 61 | MP0006054_spinal_hemorrhage | 1.38524941 |
| 62 | MP0002933_joint_inflammation | 1.33844661 |
| 63 | MP0003077_abnormal_cell_cycle | 1.32228799 |
| 64 | MP0002254_reproductive_system_inflammat | 1.31228985 |
| 65 | MP0008469_abnormal_protein_level | 1.29379169 |
| 66 | MP0008007_abnormal_cellular_replicative | 1.27464967 |
| 67 | MP0004510_myositis | 1.26167674 |
| 68 | MP0002019_abnormal_tumor_incidence | 1.25670140 |
| 69 | MP0003111_abnormal_nucleus_morphology | 1.25315641 |
| 70 | MP0002132_abnormal_respiratory_system | 1.25185005 |
| 71 | MP0002877_abnormal_melanocyte_morpholog | 1.24017674 |
| 72 | MP0001533_abnormal_skeleton_physiology | 1.23048417 |
| 73 | MP0008260_abnormal_autophagy | 1.18669308 |
| 74 | MP0005310_abnormal_salivary_gland | 1.16801745 |
| 75 | MP0005058_abnormal_lysosome_morphology | 1.14595772 |
| 76 | MP0004957_abnormal_blastocyst_morpholog | 1.13348415 |
| 77 | MP0002095_abnormal_skin_pigmentation | 1.10409276 |
| 78 | MP0003448_altered_tumor_morphology | 1.10245914 |
| 79 | MP0000015_abnormal_ear_pigmentation | 1.08857204 |
| 80 | MP0008058_abnormal_DNA_repair | 1.06928157 |
| 81 | MP0003172_abnormal_lysosome_physiology | 1.05153786 |
| 82 | MP0003091_abnormal_cell_migration | 1.04579906 |
| 83 | MP0008004_abnormal_stomach_pH | 1.03388902 |
| 84 | MP0005167_abnormal_blood-brain_barrier | 1.01742775 |
| 85 | MP0002332_abnormal_exercise_endurance | 1.01567570 |
| 86 | MP0005165_increased_susceptibility_to | 1.01157005 |
| 87 | MP0005164_abnormal_response_to | 1.00809810 |
| 88 | MP0010307_abnormal_tumor_latency | 0.98292350 |
| 89 | MP0000313_abnormal_cell_death | 0.96734444 |
| 90 | MP0009764_decreased_sensitivity_to | 0.92425673 |
| 91 | MP0003329_amyloid_beta_deposits | 0.92038499 |
| 92 | MP0000343_altered_response_to | 0.89471070 |
| 93 | MP0010352_gastrointestinal_tract_polyps | 0.85905954 |
| 94 | MP0003186_abnormal_redox_activity | 0.85071061 |
| 95 | * MP0001663_abnormal_digestive_system | 0.83894672 |
| 96 | MP0003690_abnormal_glial_cell | 0.82701597 |
| 97 | MP0001849_ear_inflammation | 0.81991282 |
| 98 | MP0009763_increased_sensitivity_to | 0.79333726 |
| 99 | MP0003183_abnormal_peptide_metabolism | 0.77480737 |
| 100 | MP0000477_abnormal_intestine_morphology | 0.76552438 |
| 101 | MP0008874_decreased_physiological_sensi | 0.74949905 |
| 102 | MP0004381_abnormal_hair_follicle | 0.74672190 |
| 103 | MP0002998_abnormal_bone_remodeling | 0.74251216 |
| 104 | MP0001881_abnormal_mammary_gland | 0.72784800 |
| 105 | MP0001542_abnormal_bone_strength | 0.72471686 |
| 106 | MP0009379_abnormal_foot_pigmentation | 0.72385056 |
| 107 | MP0005076_abnormal_cell_differentiation | 0.70864057 |
| 108 | MP0002138_abnormal_hepatobiliary_system | 0.70494208 |
| 109 | MP0000249_abnormal_blood_vessel | 0.68430391 |
| 110 | MP0001216_abnormal_epidermal_layer | 0.67807314 |
| 111 | MP0001851_eye_inflammation | 0.66660574 |
| 112 | MP0004858_abnormal_nervous_system | 0.64007470 |
| 113 | MP0003191_abnormal_cellular_cholesterol | 0.63898601 |
| 114 | MP0004883_abnormal_blood_vessel | 0.63517170 |
| 115 | MP0000350_abnormal_cell_proliferation | 0.61717858 |
| 116 | MP0003795_abnormal_bone_structure | 0.60943451 |
| 117 | MP0000920_abnormal_myelination | 0.60787074 |
| 118 | MP0000609_abnormal_liver_physiology | 0.60625785 |
| 119 | MP0005023_abnormal_wound_healing | 0.59629655 |
| 120 | MP0000372_irregular_coat_pigmentation | 0.59150305 |
| 121 | MP0009765_abnormal_xenobiotic_induced | 0.58346273 |
| 122 | MP0001986_abnormal_taste_sensitivity | 0.58022113 |
| 123 | MP0005647_abnormal_sex_gland | 0.55927281 |
| 124 | MP0003943_abnormal_hepatobiliary_system | 0.55618941 |
| 125 | MP0008873_increased_physiological_sensi | 0.55284015 |
| 126 | MP0003828_pulmonary_edema | 0.54557016 |
| 127 | MP0005166_decreased_susceptibility_to | 0.53345352 |
| 128 | MP0005390_skeleton_phenotype | 0.52561239 |
| 129 | MP0003279_aneurysm | 0.52104810 |
| 130 | MP0003566_abnormal_cell_adhesion | 0.51960135 |
| 131 | MP0009931_abnormal_skin_appearance | 0.51710676 |
| 132 | MP0000371_diluted_coat_color | 0.51413481 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 6.33271004 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.33271004 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.33271004 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.73233770 |
| 5 | Chronic otitis media (HP:0000389) | 4.68350947 |
| 6 | Abnormal number of erythroid precursors (HP:0012131) | 4.63987307 |
| 7 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.59787920 |
| 8 | Recurrent abscess formation (HP:0002722) | 4.41303610 |
| 9 | Dysostosis multiplex (HP:0000943) | 4.24122651 |
| 10 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.23037434 |
| 11 | Loss of speech (HP:0002371) | 3.99155369 |
| 12 | Thrombocytosis (HP:0001894) | 3.95458596 |
| 13 | Eczematoid dermatitis (HP:0000976) | 3.95444361 |
| 14 | Petechiae (HP:0000967) | 3.93597254 |
| 15 | Myositis (HP:0100614) | 3.89095387 |
| 16 | IgM deficiency (HP:0002850) | 3.83063938 |
| 17 | Disinhibition (HP:0000734) | 3.71175389 |
| 18 | Recurrent viral infections (HP:0004429) | 3.70080101 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.69479808 |
| 20 | Prolonged bleeding time (HP:0003010) | 3.61978469 |
| 21 | Recurrent bacterial skin infections (HP:0005406) | 3.58881376 |
| 22 | Systemic lupus erythematosus (HP:0002725) | 3.58823983 |
| 23 | Recurrent bronchitis (HP:0002837) | 3.54592483 |
| 24 | Pustule (HP:0200039) | 3.30371685 |
| 25 | Nasal polyposis (HP:0100582) | 3.29359271 |
| 26 | Reticulocytopenia (HP:0001896) | 3.26694885 |
| 27 | T lymphocytopenia (HP:0005403) | 3.25137338 |
| 28 | Aplastic anemia (HP:0001915) | 3.22233964 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.20091995 |
| 30 | Recurrent cutaneous fungal infections (HP:0011370) | 3.20091995 |
| 31 | Pallor (HP:0000980) | 3.13255901 |
| 32 | Abnormality of T cells (HP:0002843) | 3.12777107 |
| 33 | Abnormality of the nasal mucosa (HP:0000433) | 3.12706948 |
| 34 | Axonal loss (HP:0003447) | 3.11665777 |
| 35 | Abnormality of T cell number (HP:0011839) | 3.11471808 |
| 36 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.07956478 |
| 37 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.07956478 |
| 38 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.07956478 |
| 39 | Neurofibrillary tangles (HP:0002185) | 3.07873925 |
| 40 | Stomatitis (HP:0010280) | 3.03364505 |
| 41 | Panhypogammaglobulinemia (HP:0003139) | 3.03292786 |
| 42 | Mediastinal lymphadenopathy (HP:0100721) | 3.02509648 |
| 43 | Nuclear cataract (HP:0100018) | 3.01258379 |
| 44 | Epistaxis (HP:0000421) | 2.96397556 |
| 45 | Abnormality of macrophages (HP:0004311) | 2.93452596 |
| 46 | Mucopolysacchariduria (HP:0008155) | 2.91164547 |
| 47 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.91164547 |
| 48 | Recurrent skin infections (HP:0001581) | 2.90722718 |
| 49 | Cellulitis (HP:0100658) | 2.89150230 |
| 50 | Autoimmune thrombocytopenia (HP:0001973) | 2.88322766 |
| 51 | Abnormality of T cell physiology (HP:0011840) | 2.86120036 |
| 52 | Meningitis (HP:0001287) | 2.84087476 |
| 53 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.83207176 |
| 54 | Mutism (HP:0002300) | 2.73259351 |
| 55 | Impaired platelet aggregation (HP:0003540) | 2.67287678 |
| 56 | Abnormal platelet function (HP:0011869) | 2.67287678 |
| 57 | Vacuolated lymphocytes (HP:0001922) | 2.66318026 |
| 58 | IgG deficiency (HP:0004315) | 2.66061149 |
| 59 | Chronic obstructive pulmonary disease (HP:0006510) | 2.64737204 |
| 60 | Obstructive lung disease (HP:0006536) | 2.64737204 |
| 61 | Gastrointestinal stroma tumor (HP:0100723) | 2.63540091 |
| 62 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.62445381 |
| 63 | Hepatosplenomegaly (HP:0001433) | 2.58565756 |
| 64 | Gastrointestinal inflammation (HP:0004386) | 2.57480432 |
| 65 | Agammaglobulinemia (HP:0004432) | 2.56559554 |
| 66 | Amyloidosis (HP:0011034) | 2.55389123 |
| 67 | Inflammation of the large intestine (HP:0002037) | 2.55276034 |
| 68 | Microcytic anemia (HP:0001935) | 2.53628872 |
| 69 | Severe combined immunodeficiency (HP:0004430) | 2.50037366 |
| 70 | Abnormality of iron homeostasis (HP:0011031) | 2.49202892 |
| 71 | B lymphocytopenia (HP:0010976) | 2.48417895 |
| 72 | Abnormality of B cell number (HP:0010975) | 2.48417895 |
| 73 | Apathy (HP:0000741) | 2.47079516 |
| 74 | Upper motor neuron abnormality (HP:0002127) | 2.45858830 |
| 75 | Lymphoma (HP:0002665) | 2.45750237 |
| 76 | Vasculitis (HP:0002633) | 2.43373388 |
| 77 | Personality changes (HP:0000751) | 2.41772281 |
| 78 | Diminished motivation (HP:0000745) | 2.41734014 |
| 79 | Lymphopenia (HP:0001888) | 2.41515540 |
| 80 | Abnormality of the prostate (HP:0008775) | 2.40818023 |
| 81 | Pulmonary infiltrates (HP:0002113) | 2.40564483 |
| 82 | Orchitis (HP:0100796) | 2.39387930 |
| 83 | Reduced antithrombin III activity (HP:0001976) | 2.38686073 |
| 84 | Combined immunodeficiency (HP:0005387) | 2.37208656 |
| 85 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.37116335 |
| 86 | Neuronal loss in central nervous system (HP:0002529) | 2.37032414 |
| 87 | Leukocytosis (HP:0001974) | 2.36896757 |
| 88 | Progressive neurologic deterioration (HP:0002344) | 2.36410343 |
| 89 | Interstitial pulmonary disease (HP:0006530) | 2.34949171 |
| 90 | Myocardial infarction (HP:0001658) | 2.34675022 |
| 91 | Thoracic kyphosis (HP:0002942) | 2.31529352 |
| 92 | Optic neuritis (HP:0100653) | 2.29950998 |
| 93 | Retrobulbar optic neuritis (HP:0100654) | 2.29950998 |
| 94 | Cerebral inclusion bodies (HP:0100314) | 2.29505843 |
| 95 | Basal ganglia calcification (HP:0002135) | 2.28163369 |
| 96 | Birth length less than 3rd percentile (HP:0003561) | 2.27750641 |
| 97 | Increased serum ferritin (HP:0003281) | 2.25738548 |
| 98 | Increased cerebral lipofuscin (HP:0011813) | 2.25609018 |
| 99 | Chronic sinusitis (HP:0011109) | 2.25458797 |
| 100 | Macrocytic anemia (HP:0001972) | 2.25223129 |
| 101 | Increased IgM level (HP:0003496) | 2.24310704 |
| 102 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.23896850 |
| 103 | Vertebral compression fractures (HP:0002953) | 2.23108449 |
| 104 | Autoimmune hemolytic anemia (HP:0001890) | 2.23016926 |
| 105 | Prolonged neonatal jaundice (HP:0006579) | 2.22683224 |
| 106 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.21725686 |
| 107 | Hypertensive crisis (HP:0100735) | 2.19923058 |
| 108 | Poikiloderma (HP:0001029) | 2.18096192 |
| 109 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.17374934 |
| 110 | Hypoplasia of the thymus (HP:0000778) | 2.15603648 |
| 111 | Spontaneous hematomas (HP:0007420) | 2.15091819 |
| 112 | Abnormality of the fingertips (HP:0001211) | 2.14820259 |
| 113 | Thyroiditis (HP:0100646) | 2.14445061 |
| 114 | Abnormality of reticulocytes (HP:0004312) | 2.13317574 |
| 115 | Granulocytopenia (HP:0001913) | 2.12921299 |
| 116 | Type I transferrin isoform profile (HP:0003642) | 2.11693442 |
| 117 | Glomerulonephritis (HP:0000099) | 2.10284830 |
| 118 | Abnormality of eosinophils (HP:0001879) | 2.09251577 |
| 119 | Hemoptysis (HP:0002105) | 2.08697566 |
| 120 | Restrictive lung disease (HP:0002091) | 2.07733543 |
| 121 | Metaphyseal irregularity (HP:0003025) | 2.07393554 |
| 122 | Gingival bleeding (HP:0000225) | 2.06037736 |
| 123 | Poikilocytosis (HP:0004447) | 2.05134244 |
| 124 | Encephalitis (HP:0002383) | 2.04819369 |
| 125 | Eosinophilia (HP:0001880) | 2.03903195 |
| 126 | Colitis (HP:0002583) | 2.01906323 |
| 127 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.00787940 |
| 128 | Abnormal platelet volume (HP:0011876) | 1.99276296 |
| 129 | Myelodysplasia (HP:0002863) | 1.98783216 |
| 130 | Amaurosis fugax (HP:0100576) | 1.97247293 |
| 131 | Urticaria (HP:0001025) | 1.97142174 |
| 132 | Hypergammaglobulinemia (HP:0010702) | 1.96169031 |
| 133 | Gingivitis (HP:0000230) | 1.95967768 |
| 134 | Agnosia (HP:0010524) | 1.95775428 |
| 135 | Skin ulcer (HP:0200042) | 1.94445239 |
| 136 | Osteomyelitis (HP:0002754) | 1.94293471 |
| 137 | Recurrent sinusitis (HP:0011108) | 1.94259686 |
| 138 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.94256570 |
| 139 | Polyneuropathy (HP:0001271) | 1.93478314 |
| 140 | Keratoconjunctivitis sicca (HP:0001097) | 1.93464975 |
| 141 | Periodontitis (HP:0000704) | 1.93019576 |
| 142 | Increased IgE level (HP:0003212) | 1.91168644 |
| 143 | Purpura (HP:0000979) | 1.90867800 |
| 144 | Arthralgia (HP:0002829) | 1.90820883 |
| 145 | J-shaped sella turcica (HP:0002680) | 1.89249978 |
| 146 | Supranuclear gaze palsy (HP:0000605) | 1.88154599 |
| 147 | Dementia (HP:0000726) | 1.82999080 |
| 148 | Polygenic inheritance (HP:0010982) | 1.78635349 |
| 149 | Hematochezia (HP:0002573) | 1.78267757 |
| 150 | Bone pain (HP:0002653) | 1.77450675 |
| 151 | Inappropriate behavior (HP:0000719) | 1.75153699 |
| 152 | Pathologic fracture (HP:0002756) | 1.74425882 |
| 153 | Malnutrition (HP:0004395) | 1.71612352 |
| 154 | Splenomegaly (HP:0001744) | 1.70705639 |
| 155 | Nausea (HP:0002018) | 1.69820847 |
| 156 | Keratoconjunctivitis (HP:0001096) | 1.69132968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.29895530 |
| 2 | KIT | 3.02638006 |
| 3 | TXK | 2.80655597 |
| 4 | JAK3 | 2.75695761 |
| 5 | PRPF4B | 2.62372410 |
| 6 | TBK1 | 2.45803568 |
| 7 | ZAP70 | 2.38564454 |
| 8 | PIM2 | 2.20739501 |
| 9 | IKBKE | 2.20601280 |
| 10 | EEF2K | 2.15575779 |
| 11 | TYK2 | 2.13221297 |
| 12 | DDR2 | 2.12252281 |
| 13 | GRK7 | 2.07851655 |
| 14 | BTK | 2.01547644 |
| 15 | IRAK4 | 1.98455770 |
| 16 | TEC | 1.98147450 |
| 17 | FLT3 | 1.86995418 |
| 18 | BLK | 1.84956306 |
| 19 | TESK1 | 1.77008727 |
| 20 | MAP3K14 | 1.74941366 |
| 21 | STK16 | 1.73884292 |
| 22 | SYK | 1.69899765 |
| 23 | IKBKB | 1.61163478 |
| 24 | RPS6KA4 | 1.60383697 |
| 25 | CSF1R | 1.56842347 |
| 26 | STK10 | 1.56288922 |
| 27 | FGR | 1.54453322 |
| 28 | MOS | 1.54397658 |
| 29 | MAP2K3 | 1.50553114 |
| 30 | NLK | 1.46370740 |
| 31 | TGFBR2 | 1.45726292 |
| 32 | PKN2 | 1.45154345 |
| 33 | EIF2AK1 | 1.41026355 |
| 34 | PIM1 | 1.39910532 |
| 35 | LCK | 1.39079597 |
| 36 | ABL2 | 1.34006705 |
| 37 | CDC42BPA | 1.32704339 |
| 38 | KDR | 1.31122873 |
| 39 | TLK1 | 1.30228201 |
| 40 | IRAK3 | 1.30169605 |
| 41 | BMPR2 | 1.27583182 |
| 42 | CLK1 | 1.26404068 |
| 43 | ACVR1B | 1.24603109 |
| 44 | TGFBR1 | 1.24369097 |
| 45 | LRRK2 | 1.24040624 |
| 46 | EPHA2 | 1.24031992 |
| 47 | MATK | 1.20487731 |
| 48 | LYN | 1.19005213 |
| 49 | GRK6 | 1.18292721 |
| 50 | SMG1 | 1.17401282 |
| 51 | ARAF | 1.16111349 |
| 52 | WEE1 | 1.15858802 |
| 53 | TAOK3 | 1.12036040 |
| 54 | RIPK1 | 1.10596936 |
| 55 | MAP3K10 | 1.10124194 |
| 56 | CDC7 | 1.10062419 |
| 57 | SCYL2 | 1.09753856 |
| 58 | ITK | 1.09679028 |
| 59 | HCK | 1.07723046 |
| 60 | MAP3K11 | 1.07622729 |
| 61 | MAP3K1 | 1.06170413 |
| 62 | FES | 1.01460713 |
| 63 | NEK2 | 0.98269212 |
| 64 | MST1R | 0.96038991 |
| 65 | FGFR4 | 0.95134593 |
| 66 | RIPK4 | 0.93212732 |
| 67 | PAK4 | 0.92636454 |
| 68 | ICK | 0.90982413 |
| 69 | ERN1 | 0.90304756 |
| 70 | JAK1 | 0.89344840 |
| 71 | CHUK | 0.88483965 |
| 72 | MST4 | 0.85701090 |
| 73 | LMTK2 | 0.85474861 |
| 74 | JAK2 | 0.84543360 |
| 75 | CSK | 0.84144310 |
| 76 | RPS6KB2 | 0.83388061 |
| 77 | STK4 | 0.83205422 |
| 78 | TRIB3 | 0.83072177 |
| 79 | IRAK2 | 0.81949571 |
| 80 | CDK19 | 0.81152585 |
| 81 | CDK4 | 0.80645458 |
| 82 | BMX | 0.80266432 |
| 83 | VRK1 | 0.76654804 |
| 84 | BUB1 | 0.75814370 |
| 85 | NEK9 | 0.75195874 |
| 86 | DYRK3 | 0.70056163 |
| 87 | SIK2 | 0.69900324 |
| 88 | MAP3K5 | 0.69818653 |
| 89 | * NME2 | 0.66732602 |
| 90 | TNK2 | 0.66248001 |
| 91 | MAP3K8 | 0.64760968 |
| 92 | VRK2 | 0.64189973 |
| 93 | EIF2AK3 | 0.64157203 |
| 94 | MAPK11 | 0.63641973 |
| 95 | TAOK2 | 0.62521000 |
| 96 | ATR | 0.61346206 |
| 97 | TNIK | 0.58827826 |
| 98 | HIPK2 | 0.58432700 |
| 99 | CDK7 | 0.58115336 |
| 100 | EPHB1 | 0.57540966 |
| 101 | TRPM7 | 0.56339420 |
| 102 | AURKB | 0.54980595 |
| 103 | MAP2K6 | 0.54451482 |
| 104 | LIMK1 | 0.54039465 |
| 105 | BCKDK | 0.51847123 |
| 106 | RPS6KA5 | 0.51050506 |
| 107 | TESK2 | 0.50308652 |
| 108 | MKNK1 | 0.50189467 |
| 109 | FGFR3 | 0.49753761 |
| 110 | MKNK2 | 0.49363473 |
| 111 | PRKG2 | 0.48721756 |
| 112 | SIK1 | 0.47974790 |
| 113 | CDK6 | 0.47011251 |
| 114 | BRSK2 | 0.46933945 |
| 115 | RPS6KL1 | 0.46843568 |
| 116 | RPS6KC1 | 0.46843568 |
| 117 | RPS6KA6 | 0.46271800 |
| 118 | DAPK3 | 0.45184472 |
| 119 | IRAK1 | 0.45080919 |
| 120 | MARK3 | 0.44423523 |
| 121 | DAPK1 | 0.43782539 |
| 122 | PDGFRA | 0.43284086 |
| 123 | MAP3K3 | 0.42367685 |
| 124 | TAOK1 | 0.41603458 |
| 125 | ADRBK2 | 0.41092783 |
| 126 | CDK8 | 0.40840968 |
| 127 | TTN | 0.40235651 |
| 128 | MAPKAPK2 | 0.39050634 |
| 129 | MUSK | 0.39005565 |
| 130 | MAP3K13 | 0.37876659 |
| 131 | SIK3 | 0.35343145 |
| 132 | PASK | 0.35258329 |
| 133 | PRKCD | 0.33979332 |
| 134 | MAPK4 | 0.33856447 |
| 135 | MAPKAPK5 | 0.33727554 |
| 136 | ABL1 | 0.32858342 |
| 137 | PDPK1 | 0.32123159 |
| 138 | PRKD2 | 0.30894596 |
| 139 | BRAF | 0.26443724 |
| 140 | PRKCQ | 0.26316870 |
| 141 | PAK1 | 0.26027156 |
| 142 | GSK3A | 0.23683012 |
| 143 | RPS6KA2 | 0.22790450 |
| 144 | PDK1 | 0.22494470 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.42724078 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.40224968 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.04492758 |
| 4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.36226250 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.22666907 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 2.20158047 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.17730888 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.09012722 |
| 9 | Base excision repair_Homo sapiens_hsa03410 | 2.05785156 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.96526930 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.94754620 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.94744220 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.94236045 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.88549017 |
| 15 | Homologous recombination_Homo sapiens_hsa03440 | 1.74152127 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.73474596 |
| 17 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.68625942 |
| 18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.65376821 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.65349886 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.60342440 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.52464685 |
| 22 | Spliceosome_Homo sapiens_hsa03040 | 1.46418017 |
| 23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.45045015 |
| 24 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.44999779 |
| 25 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.44749788 |
| 26 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.43846617 |
| 27 | Allograft rejection_Homo sapiens_hsa05330 | 1.43522277 |
| 28 | Legionellosis_Homo sapiens_hsa05134 | 1.42275720 |
| 29 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.42096653 |
| 30 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.35558282 |
| 31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.34332152 |
| 32 | Proteasome_Homo sapiens_hsa03050 | 1.33997481 |
| 33 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.31839689 |
| 34 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.29121910 |
| 35 | Other glycan degradation_Homo sapiens_hsa00511 | 1.28864444 |
| 36 | Malaria_Homo sapiens_hsa05144 | 1.28335037 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.26070740 |
| 38 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.24690332 |
| 39 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.24548009 |
| 40 | Influenza A_Homo sapiens_hsa05164 | 1.22419263 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 1.21164479 |
| 42 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.20267221 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 1.19267469 |
| 44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.19248129 |
| 45 | RNA polymerase_Homo sapiens_hsa03020 | 1.18853791 |
| 46 | Pertussis_Homo sapiens_hsa05133 | 1.17528463 |
| 47 | Bladder cancer_Homo sapiens_hsa05219 | 1.15880857 |
| 48 | Asthma_Homo sapiens_hsa05310 | 1.13915773 |
| 49 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.12502568 |
| 50 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.11922492 |
| 51 | Tuberculosis_Homo sapiens_hsa05152 | 1.10030488 |
| 52 | Cell cycle_Homo sapiens_hsa04110 | 1.09498533 |
| 53 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.03010814 |
| 54 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.02780750 |
| 55 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.01382533 |
| 56 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.00123628 |
| 57 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.97288348 |
| 58 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.96971215 |
| 59 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.95927402 |
| 60 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.94579697 |
| 61 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93404923 |
| 62 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.93320051 |
| 63 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.93189722 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.92929725 |
| 65 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.91879714 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.90457465 |
| 67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.89236820 |
| 68 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.88064993 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.87661072 |
| 70 | Platelet activation_Homo sapiens_hsa04611 | 0.84538705 |
| 71 | Salmonella infection_Homo sapiens_hsa05132 | 0.84192378 |
| 72 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.83329944 |
| 73 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.82918938 |
| 74 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81005867 |
| 75 | RNA degradation_Homo sapiens_hsa03018 | 0.80432892 |
| 76 | HTLV-I infection_Homo sapiens_hsa05166 | 0.80248057 |
| 77 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.78655622 |
| 78 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.78170834 |
| 79 | RNA transport_Homo sapiens_hsa03013 | 0.77236704 |
| 80 | Protein export_Homo sapiens_hsa03060 | 0.75787755 |
| 81 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.73039710 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.72673015 |
| 83 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.72546162 |
| 84 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.72131229 |
| 85 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.71164406 |
| 86 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.71160368 |
| 87 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.69914819 |
| 88 | Hepatitis C_Homo sapiens_hsa05160 | 0.69575525 |
| 89 | Thyroid cancer_Homo sapiens_hsa05216 | 0.68391902 |
| 90 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.67945772 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | 0.67748273 |
| 92 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64941987 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63370283 |
| 94 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.62425516 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.61042912 |
| 96 | Lysosome_Homo sapiens_hsa04142 | 0.57522383 |
| 97 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.57311163 |
| 98 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.55279321 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54348470 |
| 100 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.54131009 |
| 101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53825786 |
| 102 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53555817 |
| 103 | Purine metabolism_Homo sapiens_hsa00230 | 0.53288686 |
| 104 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53128745 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53015001 |
| 106 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.52605996 |
| 107 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52427011 |
| 108 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51239591 |
| 109 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.50361028 |
| 110 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50093419 |
| 111 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50060487 |
| 112 | Basal transcription factors_Homo sapiens_hsa03022 | 0.47469419 |
| 113 | Colorectal cancer_Homo sapiens_hsa05210 | 0.46103322 |
| 114 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.42759059 |
| 115 | Endocytosis_Homo sapiens_hsa04144 | 0.42491232 |
| 116 | Phagosome_Homo sapiens_hsa04145 | 0.38580243 |
| 117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38351565 |
| 118 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.37108935 |
| 119 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.36438735 |
| 120 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.36021724 |
| 121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.30197681 |
| 122 | Mineral absorption_Homo sapiens_hsa04978 | 0.28187807 |
| 123 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.23740519 |
| 124 | Insulin resistance_Homo sapiens_hsa04931 | 0.20578852 |
| 125 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.18127284 |
| 126 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.15138126 |
| 127 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.14041670 |
| 128 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.13539704 |
| 129 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.11210975 |
| 130 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.10641520 |

